Nath Bio-Genes (India) Limited (NATHBIOGEN) — share transfer | 23 July 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Submitted compliance certificate for quarter ended 30 June 2026 under SEBI Regulation 74(5).
💡 Investor Takeaway
The filing confirms routine regulatory compliance with no material impact on shareholding or trading.

Nath Bio-Genes submitted a compliance certificate to BSE and NSE confirming that securities dematerialized by Bigshare Services were accepted and listed by 30 June 2026, with certificates cancelled and member register updated within 15 days as required by SEBI Regulation 74(5).

📄 View Original Announcement (PDF)

About Nath Bio-Genes (India) Limited (NATHBIOGEN)

Fast Moving Consumer Goods · FMCG · Listed on NSE

Market Cap: ₹289.43 Cr P/E: 7.8 ROE: 6.0% ROCE: 7.9% Div Yield: 1.31%

View full NATHBIOGEN stock details →

📡 Get AI alerts when NATHBIOGEN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NATHBIOGEN — Free

📊 More NATHBIOGEN filings

See all NATHBIOGEN filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NATHBIOGEN files new disclosures

Track NATHBIOGEN filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NATHBIOGEN — Free

Free account · 2 AI queries/day